Importance of Measured Body Fat, Visceral Adiposity Index, and Lipid Accumulation Product Index in Predicting Cardiometabolic Risk Factors

Basit Öğe Kaydı
dc.contributor.authorDemirbas, Nur
dc.contributor.authorKutlu, Ruhusen
dc.date.accessioned2024-02-23T14:20:58Z
dc.date.available2024-02-23T14:20:58Z
dc.date.issued2021
dc.departmentNEÜen_US
dc.description.abstractBackground: Obesity, which is defined as excessive fat accumulation in the body, is an important public health problem. Objective: The aim of this study was to compare measured body fat and the visceral adiposity index (VAI) and lipid accumulation product (LAP) index used to predict cardiometabolic risk (CMR) factors. Methods: This study was performed retrospectively by scanning the files of 817 participants who had bioelectrical impedance analysis (BIA) results and routine blood tests. The VAI and the LAP index were calculated using the appropriate formulas. Results: Of the 817 participants included in the study, 67.9% (n = 555) were female, 32.1% (n = 262) were male, and the mean age was 36.14 +/- 11.4 (18-65) years. The mean body mass index (BMI) was 29.90 +/- 6.6 kg/m(2) and 24.2% (n = 198) of the participants were of normal weight (BMI <25 kg/m(2)), while 75.8% (n = 619) were overweight or obese (BMI >= 25 kg/m(2)). Body fat quantity was higher in females than in males. As BMI increased, the body fat quantity measured by BIA also increased (P < 0.001). The mean LAP index of men was higher than the mean LAP index of women in both the normal-weight group and the obese group (P = 0.025 and P = 0.033, respectively). One unit increase in visceral fat percentage resulted in a 77.9% increase in CMR. Conclusions: It may not be sufficient to use only BMI to predict obesity and related cardiometabolic diseases. According to the study findings, it was determined that the increase in visceral fat percentage significantly increases the CMR.en_US
dc.identifier.doi10.1089/met.2020.0098
dc.identifier.endpage179en_US
dc.identifier.issn1540-4196
dc.identifier.issn1557-8518
dc.identifier.issue3en_US
dc.identifier.pmid33121374en_US
dc.identifier.scopus2-s2.0-85103080712en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage174en_US
dc.identifier.urihttps://doi.org/10.1089/met.2020.0098
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13386
dc.identifier.volume19en_US
dc.identifier.wosWOS:000586560500001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.ispartofMetabolic Syndrome And Related Disordersen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectObesityen_US
dc.subjectVaien_US
dc.subjectLapen_US
dc.subjectBioelectrical Impedance Analysisen_US
dc.titleImportance of Measured Body Fat, Visceral Adiposity Index, and Lipid Accumulation Product Index in Predicting Cardiometabolic Risk Factorsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu